Home/Filings/4/0001181431-11-009589

4//SEC Filing

van der Meer Pieter 4

Accession 0001181431-11-009589

CIK 0001407038other

View on SEC.gov Company Profile

Filed

Feb 10, 7:00 PM ET

Accepted

Feb 11, 5:37 PM ET

Size

37.5 KB

Accession

0001181431-11-009589

Insider Transaction Report

Form 4

Period: 2011-02-09

BG Medicine, Inc.BGMD

van der Meer Pieter

Director10% Owner

Transactions

Conversion
Common Stock
2011-02-09+1,541,125→ 1,541,125 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
Conversion
Common Stock
2011-02-09$7.00/sh+151,450$1,060,150→ 1,692,575 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
Purchase
Common Stock
2011-02-09$7.00/sh+142,857$999,999→ 1,835,432 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
Conversion
Series A Preferred Stock
2011-02-09−4,711,820→ 0 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
→ Common Stock (1,321,045 underlying)
Conversion
Series D Preferred Stock
2011-02-09−366,809→ 0 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
→ Common Stock (220,080 underlying)
Conversion
Convertible Promissory Notes
2011-02-09→ 0 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
Exercise: $7.00→ Common Stock (151,450 underlying)
Purchase
Warrant to Purchase Common Stock
2010-09-27$0.02/sh+23,080$462→ 23,080 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
Exercise: $0.02Exp: 2020-09-27→ Common Stock (23,080 underlying)
Purchase
Warrant to Purchase Common Stock
2010-11-04$0.02/sh+23,080$462→ 23,080 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
Exercise: $0.02Exp: 2020-11-04→ Common Stock (23,080 underlying)
Purchase
Convertible Promissory Note
2010-09-27→ 0 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
→ Common Stock
Purchase
Convertible Promissory Note
2010-11-04→ 0 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
→ Common Stock

Gilde Agribusiness Management B.V.

10% Owner

Transactions

Purchase
Common Stock
2011-02-09$7.00/sh+142,857$999,999→ 1,835,432 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
Conversion
Series A Preferred Stock
2011-02-09−4,711,820→ 0 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
→ Common Stock (1,321,045 underlying)
Conversion
Series D Preferred Stock
2011-02-09−366,809→ 0 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
→ Common Stock (220,080 underlying)
Conversion
Convertible Promissory Notes
2011-02-09→ 0 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
Exercise: $7.00→ Common Stock (151,450 underlying)
Purchase
Warrant to Purchase Common Stock
2010-09-27$0.02/sh+23,080$462→ 23,080 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
Exercise: $0.02Exp: 2020-09-27→ Common Stock (23,080 underlying)
Purchase
Warrant to Purchase Common Stock
2010-11-04$0.02/sh+23,080$462→ 23,080 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
Exercise: $0.02Exp: 2020-11-04→ Common Stock (23,080 underlying)
Purchase
Convertible Promissory Note
2010-09-27→ 0 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
→ Common Stock
Purchase
Convertible Promissory Note
2010-11-04→ 0 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
→ Common Stock
Conversion
Common Stock
2011-02-09+1,541,125→ 1,541,125 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
Conversion
Common Stock
2011-02-09$7.00/sh+151,450$1,060,150→ 1,692,575 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)

Gilde Healthcare Holding B.V.

10% Owner

Transactions

Conversion
Common Stock
2011-02-09+1,541,125→ 1,541,125 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
Conversion
Common Stock
2011-02-09$7.00/sh+151,450$1,060,150→ 1,692,575 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
Purchase
Common Stock
2011-02-09$7.00/sh+142,857$999,999→ 1,835,432 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
Conversion
Series A Preferred Stock
2011-02-09−4,711,820→ 0 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
→ Common Stock (1,321,045 underlying)
Conversion
Series D Preferred Stock
2011-02-09−366,809→ 0 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
→ Common Stock (220,080 underlying)
Conversion
Convertible Promissory Notes
2011-02-09→ 0 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
Exercise: $7.00→ Common Stock (151,450 underlying)
Purchase
Warrant to Purchase Common Stock
2010-09-27$0.02/sh+23,080$462→ 23,080 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
Exercise: $0.02Exp: 2020-09-27→ Common Stock (23,080 underlying)
Purchase
Convertible Promissory Note
2010-09-27→ 0 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
→ Common Stock
Purchase
Convertible Promissory Note
2010-11-04→ 0 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
→ Common Stock
Purchase
Warrant to Purchase Common Stock
2010-11-04$0.02/sh+23,080$462→ 23,080 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
Exercise: $0.02Exp: 2020-11-04→ Common Stock (23,080 underlying)

de Graaf Edwin

10% Owner

Transactions

Conversion
Common Stock
2011-02-09+1,541,125→ 1,541,125 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
Purchase
Common Stock
2011-02-09$7.00/sh+142,857$999,999→ 1,835,432 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
Conversion
Series D Preferred Stock
2011-02-09−366,809→ 0 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
→ Common Stock (220,080 underlying)
Purchase
Warrant to Purchase Common Stock
2010-09-27$0.02/sh+23,080$462→ 23,080 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
Exercise: $0.02Exp: 2020-09-27→ Common Stock (23,080 underlying)
Conversion
Common Stock
2011-02-09$7.00/sh+151,450$1,060,150→ 1,692,575 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
Conversion
Series A Preferred Stock
2011-02-09−4,711,820→ 0 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
→ Common Stock (1,321,045 underlying)
Conversion
Convertible Promissory Notes
2011-02-09→ 0 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
Exercise: $7.00→ Common Stock (151,450 underlying)
Purchase
Warrant to Purchase Common Stock
2010-11-04$0.02/sh+23,080$462→ 23,080 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
Exercise: $0.02Exp: 2020-11-04→ Common Stock (23,080 underlying)
Purchase
Convertible Promissory Note
2010-09-27→ 0 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
→ Common Stock
Purchase
Convertible Promissory Note
2010-11-04→ 0 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
→ Common Stock

Gilde Europe Food & Agribusiness Fund B.V.

10% Owner

Transactions

Conversion
Common Stock
2011-02-09+1,541,125→ 1,541,125 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
Conversion
Common Stock
2011-02-09$7.00/sh+151,450$1,060,150→ 1,692,575 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
Purchase
Common Stock
2011-02-09$7.00/sh+142,857$999,999→ 1,835,432 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
Conversion
Series A Preferred Stock
2011-02-09−4,711,820→ 0 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
→ Common Stock (1,321,045 underlying)
Conversion
Series D Preferred Stock
2011-02-09−366,809→ 0 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
→ Common Stock (220,080 underlying)
Conversion
Convertible Promissory Notes
2011-02-09→ 0 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
Exercise: $7.00→ Common Stock (151,450 underlying)
Purchase
Warrant to Purchase Common Stock
2010-09-27$0.02/sh+23,080$462→ 23,080 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
Exercise: $0.02Exp: 2020-09-27→ Common Stock (23,080 underlying)
Purchase
Warrant to Purchase Common Stock
2010-11-04$0.02/sh+23,080$462→ 23,080 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
Exercise: $0.02Exp: 2020-11-04→ Common Stock (23,080 underlying)
Purchase
Convertible Promissory Note
2010-09-27→ 0 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
→ Common Stock
Purchase
Convertible Promissory Note
2010-11-04→ 0 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
→ Common Stock

Perret Marc Olivier

10% Owner

Transactions

Conversion
Common Stock
2011-02-09+1,541,125→ 1,541,125 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
Conversion
Common Stock
2011-02-09$7.00/sh+151,450$1,060,150→ 1,692,575 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
Purchase
Common Stock
2011-02-09$7.00/sh+142,857$999,999→ 1,835,432 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
Conversion
Series A Preferred Stock
2011-02-09−4,711,820→ 0 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
→ Common Stock (1,321,045 underlying)
Conversion
Series D Preferred Stock
2011-02-09−366,809→ 0 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
→ Common Stock (220,080 underlying)
Conversion
Convertible Promissory Notes
2011-02-09→ 0 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
Exercise: $7.00→ Common Stock (151,450 underlying)
Purchase
Warrant to Purchase Common Stock
2010-09-27$0.02/sh+23,080$462→ 23,080 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
Exercise: $0.02Exp: 2020-09-27→ Common Stock (23,080 underlying)
Purchase
Warrant to Purchase Common Stock
2010-11-04$0.02/sh+23,080$462→ 23,080 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
Exercise: $0.02Exp: 2020-11-04→ Common Stock (23,080 underlying)
Purchase
Convertible Promissory Note
2010-09-27→ 0 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
→ Common Stock
Purchase
Convertible Promissory Note
2010-11-04→ 0 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
→ Common Stock

Gilde Europe Food & Agribusiness Partners II C.V.

10% Owner

Transactions

Conversion
Common Stock
2011-02-09+1,541,125→ 1,541,125 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
Conversion
Common Stock
2011-02-09$7.00/sh+151,450$1,060,150→ 1,692,575 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
Purchase
Common Stock
2011-02-09$7.00/sh+142,857$999,999→ 1,835,432 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
Conversion
Series A Preferred Stock
2011-02-09−4,711,820→ 0 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
→ Common Stock (1,321,045 underlying)
Conversion
Series D Preferred Stock
2011-02-09−366,809→ 0 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
→ Common Stock (220,080 underlying)
Conversion
Convertible Promissory Notes
2011-02-09→ 0 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
Exercise: $7.00→ Common Stock (151,450 underlying)
Purchase
Warrant to Purchase Common Stock
2010-09-27$0.02/sh+23,080$462→ 23,080 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
Exercise: $0.02Exp: 2020-09-27→ Common Stock (23,080 underlying)
Purchase
Warrant to Purchase Common Stock
2010-11-04$0.02/sh+23,080$462→ 23,080 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
Exercise: $0.02Exp: 2020-11-04→ Common Stock (23,080 underlying)
Purchase
Convertible Promissory Note
2010-09-27→ 0 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
→ Common Stock
Purchase
Convertible Promissory Note
2010-11-04→ 0 total(indirect: By Gilde Europe Food & Agribusiness Fund B.V.)
→ Common Stock

Footnotes (12)

[F1]The manager of Gilde Europe Food & Agribusiness Fund B.V. is Gilde Agribusiness Management B.V., which is indirectly owned by three managing partners, Pieter van der Meer, Edwin de Graaf and Marc Olivier Perret, through a holding entity, Gilde Healthcare Holding B.V. Gilde Healthcare Holding B.V. is owned in equal thirds by the three managing partners. Gilde Europe Food & Agribusiness Partners II C.V. has a 20% carried interest in Gilde Europe Food & Agribusiness Fund B.V. Pieter van der Meer, Edwin de Graaf and Marc Olivier Perret together have a controlling interest in Gilde Europe Food & Agribusiness Partners II C.V. Each of Pieter van der Meer, Edwin de Graaf, and Marc Olivier Perret disclaim beneficial ownership of the securities except to the extent of his pecuniary interest therein.
[F10]Not applicable.
[F11]The outstanding principal and accrued and unpaid interest on the Convertible Notes automatically converted into Common Stock upon the closing of the Issuer's initial public offering at $7.00 per share pursuant to the terms of the Convertible Notes.
[F12]Reflects the principal amount of the Convertible Note.
[F2]The Preferred Stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering pursuant to the Issuer's Restated Certificate of Incorporation, as amended, based on the conversion rate in effect at the time of conversion. The Series A Preferred Stock converted to Common Stock on an approximately 1-for-0.2804 basis and the Series D Preferred Stock converted to Common Stock on an approximately 1-for-0.6 basis.
[F3]Reflects the shares issued as a result of the automatic conversion of the outstanding principal and accrued and unpaid interest on the Convertible Notes (defined herein) through February 9, 2011, the closing date of the Issuer's initial public offering, into Common Stock upon the closing of the Issuer's initial public offering pursuant to the terms of the Convertible Notes.
[F4]Reflects shares purchased in the Issuer's initial public offering.
[F5]The Series A Preferred Stock and the Series D Preferred Stock automatically converted into shares of Common Stock upon consummation of the Issuer's initial public offering and had no expiration date.
[F6]Reflects the aggregate principal amount of convertible promissory notes (the "Convertible Notes") dated April 1, 2010, September 27, 2010 and November 4, 2010.
[F7]This transaction, which occurred prior to the Issuer's initial public offering of Common Stock, is being reported as required by Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended.
[F8]Reflects the 1-for-1.6667 reverse stock split effected on November 29, 2010 in connection with the Issuer's initial public offering, pursuant to which (i) the number of shares of Common Stock underlying the warrant was divided by 1.6667 and (ii) the exercise price of the warrant was multipled by 1.6667.
[F9]The warrant became exercisable upon the closing of the Issuer's initial public offering.

Documents

1 file

4
rrd300396.xmlPrimary
FORM 4 - PIETER VAN DER MEER/GILDE

Issuer

BG Medicine, Inc.

CIK 0001407038

→

Entity typeother

Related Parties

filerCIK 0001419267

Filing Metadata

Form type: 4
Filed: Feb 10, 7:00 PM ET
Accepted: Feb 11, 5:37 PM ET
Size: 37.5 KB

View on SEC.gov